Medwave Receives Frost & Sullivan Customer Value Enhancement Award in Patient Monitoring Industry.

BOSTON -- Frost & Sullivan will present Medwave, Inc. (NASDAQ:MDWV), with the 2005 Customer Value Enhancement Award at tonight's third annual Excellence in Customer Value Enhancement Awards Banquet in recognition of Medwave's innovative technology and strategic partnerships in the non-invasive blood pressure monitors market.

Addressing the need for accurate and effective non-invasive blood pressure monitors in new and expanding patient care settings, Medwave's strategic partnerships with Nihon Kohden Corporation, Zoll Medical Corporation and Analogic Corporation help enhance the value of its monitoring solutions as well as broaden the treatment capabilities of healthcare professionals.

"As issues such as staff shortages combined with shortened acute treatment stays and increased efforts in emergency resuscitation continue to strain healthcare delivery, the impact of Medwave's key partnerships will carry great influence in the healthcare market," says Frost & Sullivan research analyst Nathan Cohen 

Medwave's products enable medical professionals to not only continuously monitor patients during procedures and extended stays with the accuracy similar to invasive sensors, but also precisely assess vitals for rapid diagnosis in emergencies. Medwave's sensor technology utilizes a force application over the radial artery to read arterial blood pressure faster and more accurately than cuffs, and on a broader group of patients including pediatric to the morbidly obese. An adjustable strap secures the device to the wrist and allows pediatric and uncooperative patients to move without affecting blood pressure measurements.

Through integration with Zoll's line of defibrillators and Analogic's series of patient monitors, Medwave enhances the customer value of its products, bringing its technology to multiple monitoring parameters and emergency treatment devices. Medwave's clinical end users now have the ability to use their preferred blood pressure monitor in conjunction with other market-leading monitoring and treatment technologies. Further, Zoll and Analogic's existing customers can select superior monitoring technology for future purchases and upgrades.

"In highly competitive markets such as the ones for defibrillators and multiparameter monitors, unique and proprietary technology can be a significant competitive advantage," says Cohen. "As such, the installed base of Medwave's devices will not only increase through the current distribution of Zoll and Analogic multiparameter instruments, but also by the potential for increased sales experienced by partners delivering their customers enhanced value using Medwave technology."

As unit volumes increase, greater availability of Medwave's devices will provide medical professionals with superior monitoring capability. In hospitals, the devices will offer more accurate non-invasive monitoring, enhanced patient comfort, and increased frequency of blood pressure measurements. For emergency resuscitation and treatment, the devices will allow first responders and emergency caregivers to more accurately diagnose and monitor victims and ultimately improve survival rates after cardiac arrest or trauma.

As clinicians and patients continue to benefit from this innovative technology, Medwave should now be in a position for significant market expansion and greater enhancement of patient safety. For its innovative technology, strategic original equipment manufacturer (OEM) partnerships, and efforts to improve patient safety, Medwave is the deserving recipient of the 2005 Customer Value Enhancement Award in the non-invasive blood pressure monitoring market.

Frost & Sullivan presents its Customer Value Enhancement Award to the company that has demonstrated the ability to expand the customer base, while maintaining its existing installed base using more innovative value creation and enhancement strategies than competing vendors. The Award lauds the recipient company's successful sales entry, customer acquisition and service strategies, and the degree to which those strategies have met customers' stated needs and requirements.

Held in Boston, Frost & Sullivan's Excellence in Customer Value Enhancement Awards banquet honors world-class companies for their outstanding performance and achievements in customer care. An annual event, the banquet recognizes innovative developments that will significantly improve customer interaction and contribute to customer satisfaction.

About Medwave, Inc.

Medwave, Inc. develops, manufactures, and distributes sensor-based non-invasive blood pressure solutions. Its Vasotrax(R) Hand Held Monitor, the Vasotrac(R) APM205A NIBP Monitor, the Vasotrac(R) APM205A Model DS, and the MJ23 OEM Module are new approaches to non-invasive blood pressure monitoring. Medwave's latest addition, the Legato(TM) OEM Developers Kit, is designed to introduce the innovative Vasotrac(R) technology to OEM designers. Medwave has received the necessary regulatory clearances to market its technology in Europe, Asia, and the United States. Medwave is ISO13485/ISO9001/MDD93/42/EEC certified, and its products are CE marked. Medwave has received the Seal of Acceptance from the Alliance of Children's Hospitals, as well as the Frost and Sullivan Market Engineering Award for Technology Innovation. Medwave's technology is installed in over 500 hospitals and clinics worldwide. Medwave currently has supply and/or other agreements with Nihon Kohden, Zoll Medical Corporation, Analogic Corporation, and a global electronics company. Medwave trades on the NASDAQ small cap market under the symbol MDWV. For more information, visit www.medwave.com.

About Frost & Sullivan

Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit http://www.frost.com.